journal article

PCV93 COST-EFFECTIVENESS ANALYSIS OF EZETIMIBE/SIMVASTATIN COMPARED WITH DOUBLING THE STATIN DOSE: ANALYSIS OF THE INFORCE STUDY IN THE UK

Authors
Publication date
1 October 2009
Publisher
International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Elsevier - Publisher Connector

      redirect
      oaidoi:10.1016/S1098-3015(10)7462...
      Last time updated on 05/05/2017

      Crossref

      redirect
      oaiinfo:doi/10.1016%2Fs1098-3015%...
      Last time updated on 05/06/2019

      Elsevier - Publisher Connector

      redirect
      oaidoi:10.1016/S1098-3015(10)7462...
      Last time updated on 05/06/2019